Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2020-02-14 4:40 pm Unchanged | 13D | Spero Therapeutics Inc. SPRO | GSK plc GSK | 1,934,006 10.1% | 0 (Unchanged) | View |
| 2020-02-14 4:39 pm Purchase | 13D | Principia Biopharma Inc. PRNB | GSK plc GSK | 3,042,193 9.3% | 387,857 (+14.61%) | View |
| 2020-02-14 4:39 pm Sale | 13G | GENOCEA BIOSCIENCES INC NE GNCA | GSK plc GSK | 3,676,767 7.7% | -10,880,237 (-74.74%) | View |
| 2020-02-14 4:39 pm Purchase | 13G | Progyny Inc. PGNY | GSK plc GSK | 10,526,957 12.5% | 10,526,957 (New Position) | View |
| 2020-02-14 4:38 pm Unchanged | 13D | BICYCLE THERAPEUTICS plc BCYC | GSK plc GSK | 1,915,275 10.7% | 0 (Unchanged) | View |
| 2020-02-14 4:38 pm Sale | 13D | Aileron Therapeutics Inc. ALRN | GSK plc GSK | 504,926 1.8% | -926,593 (-64.73%) | View |
| 2020-02-14 4:38 pm Sale | 13D | APPLIED GENETIC TECHNOLOGIES CORP AGTC | GSK plc GSK | 0 0% | -1,436,448 (Position Closed) | View |
| 2020-02-14 4:10 pm Purchase | 13G | Fulcrum Therapeutics Inc. FULC | GSK plc GSK | 1,785,714 7.7% | 1,785,714 (New Position) | View |
| 2020-02-14 4:09 pm Purchase | 13D | CRISPR Therapeutics AG CRSP | GSK plc GSK | 3,295,627 5.5% | 30,000 (+0.92%) | View |
| 2020-02-05 12:00 pm Purchase | 13G | GSK PLC SPONSORED ADR GSK | BlackRock Inc. BLK | 376,159,235 7.5% | 31,949,465 (+9.28%) | View |
| 2019-07-25 3:39 pm Unchanged | 13D | MORPHIC HLDG INC MORF | GSK plc GSK | 2,633,772 8.9% | 0 (Unchanged) | View |
| 2019-07-12 4:23 pm Purchase | 13D | MORPHIC HLDG INC MORF | GSK plc GSK | 2,633,772 8.9% | 2,633,772 (New Position) | View |
| 2019-06-07 2:04 pm Purchase | 13D | BICYCLE THERAPEUTICS plc BCYC | GSK plc GSK | 1,915,275 10.8% | 1,915,275 (New Position) | View |